Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Assessment of the Quality of Services at the Primary Health Care Centers



Aiming for the continuous endeavor to guarantee the provision of high quality of health care services in our primary health care centers.

The PHC team has assessed the quality of these services through field visits during the first half of 2019.

Accordingly, you can find the names of the high performing centers by governorate:
 
  • Governorate Beyrouth
    • Makhzoumi Medical center in Mazraa
  • Governorate Mount Lebanon
    • Qadaa Baabda
      • Dar El hawraa Center - Beer El- Abd
    • Qadaa El Metn
      • Socio-Medical Center - El Fanar
  • Governorate North
    • Qadaa Zgharta
      • Socio-Medical Center - Khaldiyeh
  • Governorate Akkar
    • Qadaa Akkar
      • Advanced Medical Center - Mashta Hassan
  • Governorate Bekaa
    • Qadaa Zahlé
      • Rafic Al Hariri Health Center  - Taaneyel
  • Governorate Baalbak El Hermel
    • Qadaa Baalbak
      • Laboueh health Center       
  • Governorate South
    • Qadaa Saida
      • Nabih Berri rehabilitation center for handicaps
  • Governorate El Nabatieh
    • Qadaa Marjayoun
      • Amel association - Khyam
    ...
    112
    ...
ATC Name B/G Ingredients Dosage Form Price
L01EA01 1 G I 046 335 19.35 D 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
L01EA01 1 G I India I 518 L.L
L01EA01 1 G I KSA Leb 161 L.L
L01EA01 1 G I Pabiani Poland L.L
L01EA01 2 B I Wehr Ge 531 L.L
L01EA01 2 G I 684 19.3 L.L
L01EA01 2 G I 763 090 21.26 C 18 Hikma Pharmaceuticals Jordan 3/10/2025 L.L
L01EA01 2 G I 619 185 19.35 D 3/10/2025 L.L
L01EA01 2 G I 103 200 10.71 E1 3/10/2025 L.L
L01EA01 2 G I SA Arge 083 L.L
L01EA01 2 G I 085 276 19.35 D 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
L01EA01 2 G I 144 207 19.35 D 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
L01EA01 2 G I India I 396 L.L
L01EA01 2 G I KSA Leb 473 L.L
L01EA01 2 G I Pabiani Poland L.L
L01EA02 1 B D 274 841 2.44 E2 3/10/2025 L.L
L01EA02 1 G D 688 10.7 L.L
L01EA02 1 G D 415 923 2.44 E2 616 1A Pharma GmbH Germany 3/10/2025 L.L
L01EA02 1 G D 364 905 2.44 E2 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
L01EA02 1 G D 364 905 2.44 E2 18 Hikma Pharmaceuticals Jordan 3/10/2025 L.L
L01EA02 2 B D Ontario Canada Canada 212 L.L
L01EA02 2 G D 688 10.7 L.L
L01EA02 2 G D 548 596 2.44 E2 616 1A Pharma GmbH Germany 3/10/2025 L.L
L01EA02 2 G D 364 905 2.44 E2 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
L01EA02 2 G D 364 905 2.44 E2 18 Hikma Pharmaceuticals Jordan 3/10/2025 L.L
L01EA02 3 G D 855 10.7 L.L
L01EA02 3 G D 387 571 2.44 E2 616 1A Pharma GmbH Germany 3/10/2025 L.L
L01EA02 3 G D 165 573 2.44 E2 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
L01EA02 3 G D 165 573 2.44 E2 18 Hikma Pharmaceuticals Jordan 3/10/2025 L.L
L01EA02 4 G D 729 810 2.44 E2 2911 Neapolis Pharma Tunisia 3/10/2025 L.L
    ...
    112
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025